Our data are in line with previous reports showing that inhibition of BRD4 restrains HH/GLI-dependent growth of medulloblastoma, BCC, breast and pancreatic cancers [17, 18, 23, 24]. This evidence concerns the gene BRD4 and medulloblastoma.